Identification of T-cell clones showing expansion associated with graft-vs-leukemia effect on chronic myelogenous leukemia in vivo and in vitro

Experimental Hematology

Volumn 29, Issue 4, 2001, Pages 471-476

  Kondo, Yukio ^a   Shiobara, Shintaro ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW; CASE REPORT; CELL CLONE; CELL TYPE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CRYOPRESERVATION; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MOUTH MUCOSA; PERIPHERAL LYMPHOCYTE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN MOTIF; RELAPSE; REMISSION; T LYMPHOCYTE; TIME;

ADULT; AMINO ACID SEQUENCE; BONE MARROW CELLS; CELL DIVISION; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GRAFT VS LEUKEMIA EFFECT; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTE TRANSFUSION; MOUTH MUCOSA; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0035073395     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00615-4     Document Type: Article

References (26)

1. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
2. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation; separation of graft-vs-leukemia responses from graft-vs-host disease
3. Induction of graft-vs-host disease as immunotherapy for relapsed chronic myeloid leukemia
4. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
5. Graft-vs-leukemia reactions after bone marrow transplantation
6. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients
7. - chronic myeloid leukemia in relapse after bone marrow transplantation is susceptible to remission induction by donor lymphocyte infusions
8. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-vs-host disease
9. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
10. T-cell repertoire diversity and clonal expansions in normal and clinical samples
11. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status
12. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments
13. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells
14. Human T cells respond to mouse mammary tumor virus-encoded superantigen; V β restriction and conserved evolutionary features
15. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity
16. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire
17. Characterization of T cell repertoire in patients with graft-vs-leukemia after donor lymphocyte infusion
18. Changes in T cell receptor repertoire associated with graft-vs-tumor effect and graft-vs-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion
19. Stable clonal expansion of T cells induced by bone marrow transplantation
20. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
21. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation; efficacy and toxicity of a defined T-cell dose
22. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant; the case for giving donor leukocyte transfusions before the onset of hematologic relapse
23. + cytotoxic T-lymphocyte clones from a patient with severe graft-vs-host disease after allogeneic bone marrow transplantation; implications for graft-vs-leukemia reactivity
24. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
25. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant